基本信息 产品详情 公司简介 推荐产品
网站主页 ARQ092盐酸盐 Miransertib hydrochloride
  • aladdin 阿拉丁 M413976 Miransertib hydrochloride 1313883-00-9 99%

aladdin 阿拉丁 M413976 Miransertib hydrochloride 1313883-00-9 99%

Miransertib hydrochloride
1313883-00-9
152.90 5mg 起订
659.90 25mg 起订
2159.90 100mg 起订
上海 更新日期:2026-06-10

上海阿拉丁生化科技股份有限公司

VIP3年
联系人:阿拉丁客服
电话:6206333拨打
手机:13167063860 拨打
邮箱:anhua.mao@aladdin-e.com

产品详情:

中文名称:
Miransertib hydrochloride
英文名称:
Miransertib hydrochloride
CAS号:
1313883-00-9
品牌:
阿拉丁
产地:
上海
保存条件:
-20°C储存
纯度规格:
≥99%
产品类别:
小分子和化合物库
分子式:
C27H25ClN6
分子量:
468.98
运输条件:
超低温运输
产品规格:
25mg、5mg、100mg
货号:
M413976
是否进口:

中文名:Miransertib hydrochloride

英文名:Miransertib hydrochloride

纯度:≥99%

货号:M413976

Cas号:1313883-00-9

存储温度:-20°C储存

运输条件:超低温运输

产品介绍:

Information

Miransertib (ARQ 092) HCl is a novel, orally bioavailable and selectiveAKT pathwayinhibitor exhibiting a manageable safety profile among patients with advanced solid tumors.


Targets

Akt2 (Cell-free assay); Akt1 (Cell-free assay); Akt3 (Cell-free assay) 4.5 nM; 5 nM; 16 nM


In vitro

ARQ 092 blocks membrane translocation of inactive AKT and even dephosphorylates the membrane-associated active form, thereby perturbing AKT activity. Treatment with 50-500 nM ARQ 092 significantly blocks αMβ2 integrin function in neutrophils and reduces P-selectin exposure and glycoprotein Ib/IX/V-mediated agglutination in platelets. In a large panel of diverse cancer cell lines, ARQ 092 inhibits proliferation across multiple tumor types but are most potent in leukemia, breast, endometrial, and colorectal cancer cell lines. Moreover, inhibition by ARQ 092 is more prevalent in cancer cell lines containing PIK3CA/PIK3R1 mutations compared to those with wt-PIK3CA/PIK3R1 or PTEN mutations. ARQ 092 targets the PI3K/AKT pathway and AKT specifically and reduces phosphorylation of GSK3α and GSK3β in mutation-positive cells.


In vivo

Short-term oral administration of ARQ 092 or hydroxyurea, a main therapy for sickle cell disease, diminishes heterotypic cell-cell interactions in venules of sickle cell disease mice challenged with TNF-α. ARQ 092 is well tolerated at a continuous daily dose of 60 mg or a dose of 600 mg when administered once a week, for several months. ARQ 092 is likely to inhibit the activity of all AKT isoforms in intravascular cells and thereby attenuates the process of thrombosis and inflammation in SCD patients. ARQ 092 is highly active in a subset of endometrial tumors that harbor PI3K pathway gene mutations.


Cell Research(from reference)

Cell lines:MDA-MB-453 cells; NCI-H1650 cells; KU-19-19 cells 

Concentrations:0, 0.012, 0.037, 0.11, 0.33, and 1 μM 

Incubation Time:2 h 


查看阿拉丁官网此产品相关对应页面:https://www.aladdin-e.com/zh_cn/M413976.html


盐酸米兰塞替布;Miransertib3-?[3-?[4-?(1-?aminocyclobutyl)?phenyl]?-?5-?phenyl-?3H-?imidazo[4,?5-?b]?pyridin-?2-?yl]?-2-Pyridinamine hydrochloride ; ARQ-092 hydrochloride ; Miransertib (ARQ 092) HCl

公司简介

上海阿拉丁生化科技股份有限公司是A股上市公司((股票代码:688179),专注于科研试剂的研发、生产和销售,已陆续建立多个工厂和研发中心。作为领军企业,阿拉丁始终坚持质量第一,连续13年被评为“最受欢迎试剂品牌”。 阿拉丁目前常备库存试剂产品品种超过7万种,SKU总数超过46万,产品线涵盖了化学试剂、生化试剂、药靶配体、蛋白质和抗体等多个领域,是国内少数化学试剂到生物试剂全面发展的国产试剂品牌,产品同步发布在我们国内外电商平台。

成立日期 (18年)
注册资本 14130.676万人民币
员工人数 500人以上
年营业额 ¥ 1亿以上
经营模式 工厂,试剂
主营行业 生物化工,化学试剂

Miransertib hydrochloride相关厂家报价

内容声明
拨打电话 立即询价